Alcohol Dependence: Clinical Trials

6 trials for Alcohol Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Unknown 6
Phase 31Unknown 1

Follow Alcohol Dependence: new trials by email Literature Review of Alcohol Dependence trials Research Report on Alcohol Dependence

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin-assisted Therapy for Alcohol Use Disorder
Psilocybin, Niacin - Alcohol Use Disorder, Alcohol Dependence
Phase 2UnknownUniversity of Sydney902024-09-012024-06-10
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
Prolonged exposure therapy, MDMA, Niacin - PTSD, Alcohol Use Disorder
Phase 2UnknownUniversity of Sydney1202023-09-192023-11-07
The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol Dependence
NAC 2400mg/day, Placebo - Alcohol Dependence
Phase 2UnknownSouth West Sydney Local Health District402018-08-222019-03-19
Varenicline for Alcohol Dependence
Varenicline, Placebo - Alcohol Dependence
Phase 2UnknownJohannes Gutenberg University Mainz402010-03-012010-09-15
Project RAP: Reaching Adolescents for Prevention
Brief Motivational Intervention, Assessment and list of resources, Referral to Community Resources - Alcohol Related Morbidity, Alcohol Dependence
Phase 2UnknownNational Institute on Alcohol Abuse and Alcoholism (NIAAA)14002004-10-012009-02-13
A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers
Adolescent group therapy, Transitional family therapy - Alcohol Abuse, Alcohol Dependence
Phase 2 / Phase 3UnknownThe Morton Center, Inc.1201999-07-012011-08-26

Narrower conditions

Alcoholism (6)  ·  Anxiety Disorders (1)  ·  Behavior, Addictive (1)  ·  Depression (1)  ·  Marijuana Abuse (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Substance-Related Disorders (1)

Broader conditions

Alcohol-Related Disorders (6)  ·  Chemically-Induced Disorders (6)  ·  Mental Disorders (6)  ·  Substance-Related Disorders (5)  ·  Behavior (2)  ·  Behavioral Symptoms (1)  ·  Compulsive Behavior (1)  ·  Impulsive Behavior (1)  ·  Stress Disorders, Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Niacin (2)  ·  N-Methyl-3,4-methylenedioxyamphetamine (1)  ·  Niacinamide (1)  ·  Psilocybin (1)  ·  Restraint, Physical (1)  ·  Varenicline (1)

Sponsors

University of Sydney (2)  ·  Johannes Gutenberg University Mainz (1)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)  ·  South West Sydney Local Health District (1)  ·  The Morton Center, Inc. (1)

Countries

Australia (2)  ·  United States (2)  ·  Germany (1)

Top investigators

Kirsten C Morley, PhD (2)  ·  Andrew Baille, PhD (1)  ·  Edward Bernstein, MD (1)  ·  Fehr Christoph, PD Dr. (1)  ·  Judith Bernstein, RNC, PhD (1)  ·  Kirsten Morley, PhD (1)  ·  Morris D. Stanton, PhD (1)  ·  Paul Haber, PhD (1)  ·  Paul S Haber, MBBS (1)  ·  Warren B Logge, PhD (1)

Results publications

PMID 39102049, PMID 41128676, PMID 42409408

NIH funding

2009 (1), R01AA012178 (1)